Status:
COMPLETED
Real World Efficiency of Trastuzumab in Early Breast Cancer
Lead Sponsor:
Maastricht University Medical Center
Conditions:
Breast Cancer
Eligibility:
All Genders
Brief Summary
AIM To determine the value of trastuzumab in the early breast cancer setting in the Netherlands. RESEARCH QUESTIONS / OBJECTIVES 1. Is adjuvant trastuzumab in daily practice effectively used, that i...
Eligibility Criteria
Inclusion
- All patients diagnosed with invasive stage I-III breast cancer in the years 2005, 2006 and 2007 in the participating 5 hospitals.
Exclusion
- Distant metastasis at the time of the primary diagnosis
Key Trial Info
Start Date :
May 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
2684 Patients enrolled
Trial Details
Trial ID
NCT01894711
Start Date
May 1 2010
End Date
May 1 2013
Last Update
July 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Medical Centre
Maastricht, Limburg, Netherlands, 6202 AZ Maastricht